Valuation: Senzime AB

Market Cap 61Cr 6.3Cr 5.52Cr 5.1Cr 4.69Cr 8.85Cr 607.19Cr 8.99Cr 24Cr 297.09Cr 24Cr 23Cr 1.02TCr P/E 2026 *
-
P/E 2027 * -
Enterprise Value 61Cr 6.3Cr 5.52Cr 5.1Cr 4.69Cr 8.85Cr 607.19Cr 8.99Cr 24Cr 297.09Cr 24Cr 23Cr 1.02TCr EV / Sales 2026 *
4.78x
EV / Sales 2027 * 2.99x
Free-Float
40.74%
Yield 2026 *
-
Yield 2027 * -
1 day-5.54%
1 week-11.26%
Current month-15.36%
1 month-16.04%
3 months-35.25%
6 months-31.11%
Current year-32.13%
1 week 3.66
Extreme 3.665
4.4
1 month 3.66
Extreme 3.665
4.5
Current year 3.66
Extreme 3.665
6
1 year 3.66
Extreme 3.665
7.38
3 years 3.6
Extreme 3.6
9.6
5 years 2.6
Extreme 2.605
25.4
10 years 2.6
Extreme 2.605
28.5
Manager TitleAgeSince
Chief Executive Officer 53 03/05/2023
Director of Finance/CFO 56 01/01/2022
Chief Tech/Sci/R&D Officer 50 01/01/2023
Director TitleAgeSince
Chairman 53 03/05/2023
Director/Board Member 70 01/01/2016
Director/Board Member 63 05/03/2020
Date Insider Type Main position Quantity % Market Cap.
09/12/25 Buy

Director

15,000 0.0095%
09/12/25 Sell

Director

15,000 0.0095%
28/11/25 Sell

Director

15,900 0.0101%
Change 5-day change 1-year change 3-year change Capi.($)
-5.54%-11.26%-40.41%-29.52% 6.3Cr
+0.97%+10.37%-17.80%-9.09% 18TCr
+0.11%-0.34%-7.05%-6.78% 11TCr
-1.27%-0.70%+3.80%+57.17% 5.91TCr
+0.93%-0.47%+41.62%+62.05% 5.19TCr
-2.33%+0.42%-13.63%-41.35% 4.26TCr
-2.29%-4.19% - - 3.29TCr
-1.25%-0.86%-9.77%-42.07% 2.92TCr
-1.65%-2.05%+67.06%-6.98% 2.49TCr
-1.55%-1.19%-4.93%-6.81% 2.09TCr
Average -1.39%-0.50%+2.10%-2.60% 5.45TCr
Weighted average by Cap. -0.24%+2.91%-1.60%+1.88%

Financials

2026 *2027 *
Net sales 13Cr 1.32Cr 1.16Cr 1.07Cr 98.22L 1.85Cr 127.11Cr 1.88Cr 5.01Cr 62Cr 4.95Cr 4.84Cr 214.28Cr 20Cr 2.11Cr 1.85Cr 1.71Cr 1.57Cr 2.96Cr 203.06Cr 3.01Cr 8Cr 99Cr 7.91Cr 7.73Cr 342.31Cr
Net income -6.89Cr -71.12L -62.34L -57.62L -53L -99.99L -69Cr -1.02Cr -2.7Cr -34Cr -2.67Cr -2.61Cr -115.61Cr -3.68Cr -37.99L -33.3L -30.78L -28.31L -53.41L -37Cr -54.26L -1.44Cr -18Cr -1.43Cr -1.4Cr -62Cr
Net Debt - -
Logo Senzime AB
Senzime AB (publ.) is a Sweden-based company engaged in the development, manufacture and marketing of biosensors for measuring metabolites in biological fluids, such as human blood and cell culture substrates for the pharmaceutical and healthcare segments. The Company focuses on the following application areas: medical diagnostic instruments, pharmaceutical industry, chemical processing, and food and beverage processing. As of December 31, 2011, the Company marketed three products, namely SENZ-100G, for continuous analysis of glucose in the fermentation solutions; SENZ-100L, for continuous analysis of lactate in fermentation solutions, and SENZ-200G, for continuous analysis of glucose in blood during intensive care.
Employees
59
Date Price Change Volume
21/26/21 SEK 3.665 -5.54% 1
20/26/20 SEK 3.880 +1.57% 2,65,208
17/26/17 SEK 3.820 -2.80% 1,93,517
16/26/16 SEK 3.930 -4.50% 6,38,193
15/26/15 SEK 4.115 -0.36% 87,973

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. SEZI Stock